Innovation Showcase

Temporary coverage is a scheme for reimbursing health products presumed to be innovative and which have a therapeutic purpose or are intended to ...







Innovative Delivery Systems for Technology Landscape | Unitaid
All phase 1 oncology trials sponsored by the National Cancer Institute between 1991 and 2002. The overall response rate for ?classic* Phase ...
Open innovation in health | Nesta
EyePoint (Nasdaq: EYPT) is a clinical-stage biopharmaceutical company committed to developing and commercializing innovative therapeutics to help improve ...
Oncoinvent to Present at TD Cowen Radiopharmaceutical ...
UZEDY is currently approved in the US as a subcutaneous long-acting injectable (LAI) for use every one or two months for the treatment of ...



Autres Cours:

guideline-clinical-investigation-medicinal-products-treatment ... - EMA